What if you could anticipate clinical trial outcomes months ahead of time?
STAT Trials Pulse is the most advanced early warning system for clinical trial updates, trusted by the leading hedge funds, pharmaceutical companies, and biotech firms.
Be the first to know about important shifts in clinical trials including roadblocks, results, recruitment activity, regulatory updates, timeline delays, and more.
Customizable Watchlists
Monitor updates across clinical trials registries, scientific papers, and press releases for organizations, conditions, and interventions you care about.
Smart Alerts
Get real-time notifications for your watchlists and followed trials, along with contextual interpretation for each new update.
Global Trends
Discover the highest impact activity across drug development and regulatory approval processes.
Email Briefing
Receive a daily digest with the most important updates in your corner of the clinical trials landscape.
Coverage across 22,000 organizations, 26,000 interventions, and 5,800 diseases.
Join the new establishment of data-driven life sciences professionals who see ahead of the news.
There are over 6,800 clinical trials updates every day. Trying to analyze these changes and look for outliers is a staggering undertaking — but is also essential for investment firms and pharmaceutical companies making strategic decisions.
"The platform allows us to stay on top of clinical trials while understanding what is driving various shifts so we can prepare our next moves."
Analyst, Biopharma
$25B AUM Hedge Fund
“STAT Trials Pulse stands out by its ability to surface and classify updates in trial records – not only does it tell us that something changed, it tells me exactly what that change is. ”